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Bovine herpesvirus 1 (BHV-1), like other Alphaherpesvirinae subfamily members, establishes latency in
sensory neurons. The latency-related (LR) RNA is abundantly expressed during latency, and expression of an
LR protein is required for the latency reactivation cycle in cattle. Within LR promoter sequences, a 135-amino-
acid open reading frame (ORF) was identified, ORF-E, that is antisense to the LR RNA. ORF-E is also
downstream of the gene encoding the major viral transcriptional activator, bICP0. Strand-specific reverse
transcription-PCR demonstrated that a transcript containing ORF-E was consistently expressed in trigeminal
ganglia (TG) of latently infected calves, productively infected cultured cells, and acutely infected calves. As
expected, a late transcript encoding glycoprotein C was not detected in TG of latently infected calves. The
ORF-E transcript is polyadenylated and is expressed early when cultured bovine cells are productively infected.
Protein coding sequences containing ORF-E were fused to green fluorescent protein (GFP) to examine the
cellular localization of the putative protein. In transiently transfected mouse neuroblastoma (neuro-2A) and
human neuroblastoma (SK-N-SH) cells, the ORF-E/GFP fusion protein was detected in discreet domains
within the nucleus. In contrast, the ORF-E/GFP fusion protein was detected in the cytoplasm and nucleus of
rabbit skin cells and bovine kidney cells. As expected, the GFP protein was expressed in the cytoplasm and
nucleus of transfected cells. These studies indicate that the ORF-E transcript is consistently expressed during
latency. We suggest that the ORF-E gene regulates some aspect of the latency reactivation cycle.
Bovine herpesvirus 1 (BHV-1) establishes lifelong latency in
ganglionic neurons of the peripheral nervous system after ini-
tial replication in mucosal epithelium. Virus reactivation and
spread to other susceptible animals occur after natural and
corticosteroid-induced stress (23, 27). Infection can cause con-
junctivitis, pneumonia, genital disorders, abortions, and an up-
per respiratory infection referred to as shipping fever (28).
Since BHV-1-associated pathogenesis and shipping fever cost
the U.S. cattle industry at least $500 million per year (2),
modified live vaccines that protect cattle from disease but do
not reactivate virus from latency are desirable.
The latency-related (LR) RNA is the only abundant viral
transcript that has been detected in latently infected neurons
(20, 23, 24). A fraction of LR RNA is polyadenylated and
alternatively spliced in trigeminal ganglia (TG), suggesting that
this RNA is translated into more than one protein (10, 13). LR
gene products inhibit S-phase entry, and an LR protein is
associated with cyclin-dependent kinase 2 (cdk2) and cdc2/
cyclin complexes (13, 17). LR gene products also inhibit apo-
ptosis (7), suggesting that one important function of the LR
gene is to promote neuronal survival. A mutant BHV-1 strain
that contains three stop codons near the beginning of the LR
RNA was constructed to test whether LR proteins play a role
in virus growth in cattle (14). Calves infected with the LR
mutant exhibited diminished clinical symptoms and ocular
shedding of the virus relative to calves infected with the wild-
type and LR-rescued virus (14). Diminished levels of virus
were also detected in TG of calves acutely infected with the LR
mutant (15). Wild-type BHV-1 and the LR-rescued virus but
not the LR mutant virus reactivated from latency following
treatment with dexamethasone. During the transition from
acute infection to latency (establishment of latency), higher
levels of apoptosis occur in TG neurons of calves infected with
the LR mutant compared to calves infected with wild-type
BHV-1 (21). Taken together, these studies indicate that wild-
type expression of LR gene products is required for the latency
reactivation cycle in cattle.
A small open reading frame (ORF) was identified within the
LR promoter and named ORF-E. ORF-E is antisense to the
LR transcript and downstream of the bICP0 ORF. By using
strand-specific reverse transcription (RT)-PCR, a transcript
that encompasses ORF-E in TG of latently infected calves was
detected. In productively infected bovine cells, a polyadenyl-
ated ORF-E transcript was also detected. Sequences contain-
ing ORF-E were cloned into a mammalian expression vector
and expressed as a green fluorescent protein (GFP) fusion
protein. The ORF-E/GFP fusion protein was primarily de-
tected in the nucleus of transfected neuronal cells, whereas it
was detected in the cytoplasm and nucleus of nonneuronal
cells. These results suggest that ORF-E may play a role in the
latency reactivation cycle.
* Corresponding author. Mailing address: Department of Veteri-
nary and Biomedical Sciences, University of Nebraska, Lincoln Fair St.
at East Campus Loop, Lincoln, NE 68583-0905. Phone: (402) 472-
1890. Fax: (402) 472-9690. E-mail: cjones@unlnotes.unl.edu.
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MATERIALS AND METHODS
Cells and virus. Cells were plated at a density of 5  105 cells/100-mm plastic
dish in Earl’s modified Eagle’s medium supplemented with 5% fetal bovine
serum (FBS). Bovine kidney cells (MDBK; ATCC CCL-22) were grown in 5%
FBS, split 1:6 every 4 to 5 days, and used to propagate BHV-1.
Neuro-2A cells (ATCC CCL131) are mouse neuroblastoma cells, which were
grown in Earle’s minimal essential medium supplemented with 10% FBS. RS
cells are rabbit epidermal skin cells (ATCC CCL68) and were supplemented with
5% FBS. SK-N-SH cells (ATCC HTB 11) are human neuroblastoma cells and
were supplemented with 10% FBS. All media contained penicillin (10 U/ml) and
streptomycin (100 g/ml).
The Cooper strain of BHV-1 (wild-type virus) was obtained from the National
Veterinary Services Laboratory, Animal and Plant Health Inspection Services,
Ames, Iowa. Viral stocks were prepared by infecting MBDK cells at a multiplicity
of infection of 0.001 from a plaque-purified virus and subsequently titrated on
MDBK cells.
Animal experiments. BHV-1-free crossbred calves (250 kg) were randomly
assigned and housed in isolation rooms to prevent cross contamination. Calves
were anaesthetized with xylazine (approximately 50 mg/50 kg of body weight;
Bayer Corp., Shawnee Mission, Kans.). Calves were then inoculated with 1 ml of
a solution containing 107 PFU of virus per ml in each nostril and eye, dropwise
without scarification, for a total of 4  107 PFU per animal, as described
previously (14, 15, 26, 29). Experiments with animals were performed in accor-
dance with the American Association of Laboratory Animal Care guidelines.
Calves were housed under strict isolation containment and given antibiotics
before and after BHV-1 infection to prevent secondary bacterial infection.
Calves were euthanized at the indicated times after infection. All calves desig-
nated as being latently infected were euthanized at 60 days after infection, and
these calves were not shedding infectious virus from the nasal cavity or the eye.
Preparation of RNA and RT-PCR. RNA from cultured cells and TG was
prepared as described previously (6, 10, 13). Briefly, a guanine isothiocynate-
acidic phenol chloroform solution was used to prepare total RNA. RNA was
quantified spectrophotometrically (optical density at 260 nm) and stored at
80°C in 3 volumes of ethanol.
RNA samples were treated with 2 U of DNase I (RNase free) and 10 U of
RNasin (Promega, Madison, Wis.) per g of total RNA for 30 min at 20°C.
DNase I was removed by chloroform extraction. For random-primed cDNA
synthesis, the RNA was incubated with 0.5 g of random hexamers (Boehringer
Mannheim) and 0.5 mM deoxynucleoside triphosphate mix for 7 min at 65°C and
immediately chilled on ice. Then 16 l of reverse transcriptase mix (20 mM
Tris-Cl [pH 8.3], 50 mM KCl, 2.5 mM MgCl2, 100 mg of bovine serum albumin
per ml, 1 mM dithiothreitol, 10 U of RNasin, and 100 U of Superscript reverse
transcriptase II [Stratagene]) was added to the solution. The reaction was incu-
bated for 10 min at 20°C and then at 42°C for 45 min. Reverse transcriptase
activity was eliminated by incubation at 95°C for 5 min.
For strand-specific and oligo(dT)-primed cDNA synthesis, the RNA was in-
cubated with the specific primer and oligo(dT) and 0.5 mM deoxynucleoside
triphosphate mix for 10 min at 65°C and then placed at 50°C; 16 l of reverse
transcriptase mix was preheated to 50°C, added to the RNA, and incubated at
50°C for 1 h. Reverse transcriptase activity was eliminated by incubation at 95°C
for 5 min. PCR was performed with 2.0 l of cDNA in a 50-l solution containing
1 commercial PCR buffer (Advantage-GC cDNA PCR kit; BD Biosciences,
Palo Alto, Calif.), 200 mM deoxynucleoside triphosphate mix, 200 M each
primer, 1 l GC-Melt, and 1 l of polymerase mix (KlenTaq-1 and Deep Vent
polymerases and TaqStart antibody for the hot start). All PCR amplifications
were performed on the Omn-E Hybaid thermal cycler with the following cycle
conditions: 95°C for 3 min. (hot start), 95°C for 30 s, 57 to 65°C for 45 s, and 72°C
for 1.5 min for 30 cycles and a final step of 72°C for 5 min. Amplified products
were detected by 2% agarose gel electrophoresis.
Primers. See Fig. 1C and 4 for ORF-E primer positions and sequences.
Strand-specific primer 308, 5-CTCGAGGCAGGCGCAACGGAC-3, specifi-
cally amplifies ORF-E RNA. Primers that amplify the LR gene, IETU1, and gC
have been described elsewhere (15, 26). -Actin primers to screen reverse tran-
scriptase reactions were derived from rat sequences. The -actin primers are
5-GTGGGGCGCCCCAGGCACCA-3 and 5-CTCCTTAATGTCACGCAC
GATTTC-3. All primers were purchased from Integrated DNA Technologies
(Coralville, Iowa).
Cloning ORF-E into plasmid vectors. For identification of polyadenylation of
ORF-E, the PstI fragment that contains ORF-E was cloned into pUC19 and
pCDNA3.1() (Invitrogen, catalogue no. V790-20). Briefly, a plasmid contain-
ing the entire LR region (Fig. 1) and each vector was digested to completion with
PstI. Each fragment was agarose gel purified and used for ligation. The correct
orientation of the PstI insert was determined by restriction digestion. To study
the cellular localization of ORF-E expression, ORF-E was cloned into the
mammalian expression vector Monster Green Fluorescent Protein (phMGFP
vector; Promega, catalogue no. E6421) to generate an ORF-E/GFP fusion pro-
tein. PCR was performed on viral genomic DNA with primers that contained
unique restriction sites for amplification of ORF-E. The Forward primer is
5-GCGCGCTAGCCTGAAATATTAATGCCAAAGGC-3, and the reverse
primer is 5-TAACCCGGGAGGAGGAGGTCCTCCCTCGAGGCA-3. The
forward primer contains the first in-frame ATG for ORF-E (bold ATG) and a
unique NheI site. The reverse primer contains ORF-E sequences that encompass
the stop site of ORF-E with the actual stop codon (Fig. 4) replaced with three
glycines (TAG-GGA GGA GGA) and a unique SmaI site.
PCR was performed as described above. PCR products were digested with
SmaI at 25°C for 1 h and then NheI was added, and the reaction was incubated
at 37°C for 1 h. phMGFP was digested with SmaI, and then calf intestinal
phosphatase (New England Biolabs) and NheI were added. The digested prod-
ucts were isolated by agarose gel electrophoresis, and the PCR product was
ligated into the digested phMGFP to generate a plasmid in which ORF-E is 5
of the GFP ORF (pORF-E-GFP). Sequencing of pORF-E-GFP verified that
there were no PCR-induced mutations.
Confocal microscopy of the ORF-E fusion protein. Confocal microscopy was
used to examine the subcellular localization of ORF-E as previously described
(16). Cells were plated at a density of 2  105/well in 60-mm plastic plates (60
mm/well) 12 to 16 h prior to transfection. Then 2 g of the designated plasmids
was transfected into cells with Transit-LT1 solution as described by the manu-
facturer (Mirus, Madison, Wis.; catalog no. MIR2300). Briefly, 3 l of Transit per
g of plasmid was equilibrated with 200 l of cell medium (minus serum and
antibiotics) for 20 min. Then 2 g of the indicated plasmid was added and
incubated for 20 min. The solution was added directly to the cells and incubated
for 24 or 48 h. Live cell images were collected with a water immersion lens (40
by 60) under an Olympus FW500/BX60 confocal laser scanning microscope with
a simultaneous three-channel display mode, including the 488-nm excitation
laser and 522-nm emission filter set for GFP expression, differential interference
contrast/transmitted light (grey scale), and overplayed and merged images of the
first two.
RESULTS
Identification of a novel ORF upstream of the LR gene. The
LR gene encodes the only viral transcript (LR RNA) that is
abundantly expressed in latently infected neurons (20, 23, 24).
The LR gene partially overlaps bICP0 and is antisense to the
bICP0 transcript (Fig. 1A and B). A fraction of LR RNA is
polyadenylated and alternatively spliced in TG, suggesting that
this family of transcripts could be translated into more than
one protein (10, 13). While performing experiments with the
LR mutant virus and plasmids expressing LR gene products,
we occasionally obtained results suggesting that other func-
tional genes were located within the LR gene locus. Conse-
quently, we performed computer analysis on the region down-
stream of the bICP0 gene and in the opposite orientation of
the LR gene.
A small ORF was identified within the LR promoter, which
was designated ORF-E (Fig. 1C). ORF-E is antisense to the
LR transcript and downstream of the bICP0 ORF, but ORF-E
does not overlap bICP0 (Fig. 1C). The initiating methionine
codon for ORF-E is located at nucleotide 697, and the termi-
nating codon resides at bp 297. The LR promoter contains
multiple cis-acting motifs and has a neuron-specific binding
domain (NSB; Fig. 1C) (3, 4, 8, 18). The sequences that acti-
vate expression of the LR RNA during productive infection
contain a long AT-rich motif (40 of 53 nucleotides are A or T).
The AT-rich motif is located in a position that could promote
expression of a transcript encompassing ORF-E (Fig. 1C). Two
putative polyadenylation sites were also detected near the 3
terminus of ORF-E. HSV-1 expresses a transcript (AL) during
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FIG. 1. Location of the ORF-E gene within the BHV-1 genome. (A) Schematic representation of the BHV-1 genome. L and S indicate the
unique long and short regions, respectively. The boxes represent the inverted and terminal repeats. The map units are shown below the schematic
of the genome. The positions of immediate-early transcripts and LR transcript are presented. IE/4.2 is the immediate-early transcript that encodes
bICP4. IE/2.9 is the immediate-early transcript that encodes bICP0. One immediate-early promoter activates expression of IE/4.2 and IE/2.9, and
this immediate-early transcription unit is designated IETU1. E/2.6 is the early transcript that activates expression of E2.6, which encodes bICP0.
Exon 2 (e2) of bICP0 contains all of the protein-coding sequences of bICP0. The origin of replication (ORI) separates IETU1 from IETU2. IETU2
encodes a protein, bICP22. Solid lines in the transcript position map represent exons 1, 2, and 3. (B) Partial restriction enzyme map of the
sequences encompassing the LR gene. The locations of the LR transcripts, approximate sites for splicing of the LR RNA (dashed lines), and the
3 terminus of bICP0 are marked. (C) Expanded map of the PstI fragment that contains the LR promoter, 5 terminus of the LR transcript (13),
and the putative ORF-E transcript. The AT-rich sequences located near the start site of the LR RNA are postulated to promote ORF-E
transcription, and the arrow denotes the start sites for LR RNA transcription (nucleotide 724). The numbers indicate the mapped start sites for
LR transcription during latent and lytic infections (4, 13). The open box represents the neuron-specific binding (NSB) site within the LR promoter
(8). Also shown for reference is the termination site for bICP0 translation (bp 960) (31). ORF-E is antisense with respect to the LR gene (striped
arrow). The primers used for strand-specific RT-PCR and detection of the ORF-E transcript are listed below ORF-E.
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productive infection that is antisense to the latency-associated
transcript (LAT) (22). Taken together, these observations sug-
gested that a transcript containing ORF-E was expressed in
infected cells.
Detection of a transcript that encompasses ORF-E. We pre-
dicted that if an ORF-E transcript was expressed, it would be
small and not very abundant and thus might be difficult to
detect by standard Northern blot analysis. Consequently, we
developed oligonucleotide primers corresponding to nucleo-
tides 308 to 327 and 598 to 578 (primers 308 and 598 in Fig.
1C). Primer 308 was used for first-strand cDNA synthesis be-
cause this would yield a cDNA product that was antisense to
LR RNA but would not prime bICP0 cDNA synthesis. MDBK
(bovine kidney) cells were infected with BHV-1 for 1 h at 4°C
to synchronize virus infection. After washing and addition of
fresh medium, the cultures were incubated at 37°C, and total
RNA was extracted at different times after infection. An RT-
PCR product of the predicted size was detected as early as 3 h
after infection (Fig. 2A). The expected size of the RT-PCR
product is shown in the  lane. The PCR products were a
result of cDNA amplification because reactions without re-
verse transcriptase did not contain an amplified product (Fig.
2A, RT- lanes). As a control, random-primed RT-PCR was
performed with primers that detect -actin. Figure 2B shows
that -actin was detected from time zero through 12 h postin-
fection. Because of the viral host shut-off function (11, 12),
-actin RNA expression was not readily detected at 16 h after
infection.
The time course of ORF-E RNA expression was compared
to that of immediate-early transcription unit 1 (IETU1), the
LR gene, and a late transcript encoding glycoprotein C (gC)
(Fig. 2C). In agreement with the results in Fig. 2A, the ORF-E
transcript was detected 3 h after infection, which was similar to
the IETU1 and LR gene transcripts. In contrast, the ORF-E
transcript was detected earlier then the late gC transcript.
Cycloheximide blocking studies indicated that the ORF-E
transcript was not an immediate-early transcript (data not
shown). In summary, these results demonstrated that a tran-
script encompassing ORF-E was detected in productively in-
fected MDBK cells.
Detection of ORF-E RNA in BHV-1-infected calves. We then
tested whether ORF-E RNA was expressed in TG of BHV-1-
FIG. 3. Detection of ORF-E in TG of BHV-1-infected calves.
Calves were infected with BHV-1 as previously described (14, 30). At
4, 6, 8, 14, and 60 days postinfection, TG were collected and total RNA
was extracted as previously described (6, 13). (A, B, and C) Strand-
specific RT-PCR was performed to detect expression of ORF-E RNA
with primer 308. ORF-E-specific transcripts were detected by PCR
with primers 478 and 598. Panels A and B show a representation of two
different experiments. The number of days that the calves were in-
fected is denoted on the top of the panels. L, RNA extracted from TG
of latently infected calves (60 days after infection), included to give a
relative level of ORF-E RNA detection between acutely and latently
infected tissue. (D and F) Random-primed RT-PCR was performed to
detect gC and -actin RNA expression, respectively. (E) Strand-spe-
cific RT-PCR was performed to detect expression of the LR RNA with
the L3B reverse primer, and PCR was performed with the L3B prim-
ers. The arrow denotes the expected PCR product. The bands below
the expected products are primer dimers. Lanes: M, mock-infected
calf; L, latently infected calves; , DNA from BHV-1-infected MDBK
cells; , no-template control.
FIG. 2. Detection of ORF-E RNA by RT-PCR. MDBK cells were
infected with the Cooper isolate of BHV-1 (multiplicity of infection of
5). Total RNA was extracted at the indicated times postinfection.
(A) Strand-specific RT-PCR was conducted with primer 308 (Fig. 1C)
to synthesize cDNA. The primers for PCR were 308 and 598. (B) With
the same RNA as shown in panel A, cDNA synthesis was primed with
random primers, and -actin cDNA was amplified with the primers
described in Materials and Methods. Reactions without reverse tran-
scriptase did not yield specific amplified products with the -actin
primers (data not shown). (C) Random primers were used to synthe-
size cDNA. PCR was then performed with specific primers for ORF-E
(308 and 598), the LR gene (L3B), IETU1, and gC. Lanes , positive
controls consisting of DNA from infected cells; lanes , no-template
controls; RT, no reverse transcriptase enzyme in the reaction. PCR
products were separated on a 2% agarose gel, and the products were
visualized with ethidium bromide. The numbers above the lanes indi-
cate hours after infection. The arrows denote products of the expected
sizes from the PCR.
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infected calves. Calves were infected with BHV-1 as previously
described (14, 26, 30). TG were collected during acute infec-
tion (days 2 to 14) and latency (60 days after infection). Total
RNA was prepared as described in Materials and Methods,
and RT-PCR was performed with strand-specific primers. Low
levels of ORF-E RNA expression were detected in TG of
calves during acute infection (Fig. 3A and B). We were unable
to amplify ORF-E cDNA prior to day 6 of infection. However
the ORF-E transcript was detected at days 6, 8, and 14 postin-
fection in two of four, three of four, and three of four TG
samples, respectively. During latency, ORF-E RNA expression
was readily detected in TG of six of six calves latently infected
with BHV-1 (Fig. 3C, lanes L) with strand-specific priming for
first-strand synthesis. As expected, ORF-E RNA expression
was not detected in a mock-infected calf (lane m). All calves in
this study were defined as being latently infected because they
were not shedding infectious virus from the eyes or nose at 60
days after infection (15).
To confirm that these six calves were latently infected with
BHV-1, RT-PCR was performed to detect BHV-1 gC. As
expected, gC RNA expression was not detected in TG of the
six latently infected calves used for this study (Fig. 3D). In
contrast, LR RNA expression was detected in all latently in-
fected calves but not in the mock-infected calf (Fig. 3E, lane
M). -Actin primers detected an RT-PCR product in all sam-
ples, including that from the mock-infected calf (Fig. 3F). In all
of the reactions, no PCR product was obtained when reverse
transcriptase was omitted from the first-strand synthesis (data
not shown). In summary, these results demonstrated that the
ORF-E transcript was consistently expressed in latently in-
fected calves. The ORF-E transcript was not detected as con-
sistently in TG of acutely infected calves relative to latently
infected calves.
Localization of the 5 terminus of ORF-E RNA. 5 Rapid
amplification of cDNA ends was initially used to map the 5
terminus. Due to the extensive GC content of ORF-E se-
quences, we had difficulties obtaining unambiguous results. As
an alternative approach, a single reverse primer that was within
500 bp of the expected 5 terminus was used to generate first-
strand cDNA. Different primers were then synthesized to
“walk” down to the 5 terminus of the ORF-E transcript (for
the locations of the primers used for this study, see Fig. 4). We
were confident that amplified products were derived from the
ORF-E transcript because a strand-specific primer was used.
MDBK cells were infected with BHV-1, and total RNA was
extracted at 6 h postinfection (Fig. 5A). Figure 5A shows that
both primers used for the first-strand synthesis (primers 348
and 487) yielded the expected amplified products. When DNA
FIG. 4. Strategy for localizing the 5 and 3 ends of the ORF-E transcript. The DNA sequence of the ORF-E/LR gene region (PstI fragment
shown in Fig. 1) and positions of the primers used for the studies in Fig. 5 and 6 are shown. A partial sequence of the adjacent HindIII-L is also
presented because it contains putative polyadenylation sites for ORF-E. The ORF-E sense strand is presented. The 3 terminus of bICP0 and the
LR start site (productive infection and latency) are presented to provide landmarks. Solid lines with arrow denote the primers used for
strand-specific cDNA synthesis (primers 348 and 487). The dashed lines with arrows denote the positions of the primers used for PCR amplification
to localize the 5 terminus of the ORF-E transcript. The arrows show the directions of the primers. The shaded box indicates the region where
the 5 end is localized. The start codon for ORF-E and the putative protein-coding region of ORF-E are in bold. The positions of the primers used
to localize the 3 end of the ORF-E transcript (1 to 5) are dotted lines with an arrow and are in the directions of the respective primers. Potential
polyadenylation signals are in bold and underlined. The nucleotide numbers are those proposed for the LR gene (20).
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was the template for PCR, all primers produced the expected
product. However, when RNA was used as the template, this
was not the case. For example, when primer 29 (Fig. 4) was
used in the PCR, an amplified product was not detected when
RNA was the original template, but the expected product was
detected with DNA as the template (last four lanes in Fig. 5A,
denoted by stars).
To determine if the 5 terminus was the same in TG of
latently infected calves, RNA was extracted from TG of in-
fected calves and then subjected to a modified primer exten-
sion assay. Primer 487 was used for first-strand synthesis (Fig.
5B). For PCR, primer 487 and another primer of the same
sense (primer 348) were used to generate a PCR product. A
PCR product of about 390 bp was detected in TG of calves that
were latently (calf 1) and acutely (calf 2) infected. These prod-
ucts were derived from cDNA because the products were not
detected in reactions without reverse transcriptase. In sum-
mary, these studies demonstrated that the 5 terminus of
ORF-E RNA was localized to sequences that are 256 to
204 bp from the ORF-E initiating ATG codon (Fig. 4).
Localization of the 3 terminus of ORF-E RNA. Initially,
rapid amplification of cDNA ends was used to map the 3
terminus of the ORF-E RNA. However, inconsistent results
were obtained, and as described below, the discrepancy oc-
curred in part because of different 3 termini. A similar method
was then employed for localizing the 5 terminus of the ORF-E
RNA (see Fig. 4 for the locations of the primers). First-strand
cDNA synthesis was conducted with antisense primers. In
BHV-1-infected MDBK cells, all primers generated an RT-
PCR product (Fig. 6A). Although there were sequences
(GGGCTT, Fig. 4) that could serve as polyadenylation signals
(1), this result suggested that the polyadenylation sites were
further downstream.
Additional 3 terminus mapping studies were performed
with total RNA prepared from TG of BHV-1-infected calves.
The procedure described for Fig. 6A was used to generate
cDNA and then PCR was performed. The numbers under each
lane in Fig. 6B represent the primers used in the reverse
transcriptase reaction. Regardless of whether RNA was pre-
pared from TG of acutely infected calves or latently infected
calves, similar results were obtained with primer 2 (Fig. 6B).
Primer 1 was unable to amplify the ORF-E-specific cDNA that
was generated from total RNA prepared from TG of latently
infected calves (a representative sample is shown). However,
primer 1 did amplify ORF-E-specific cDNA in acutely infected
calves (day 6) and in latently infected calves that were treated
with dexamethasone for 21 h to initiate reactivation from la-
tency. In summary, these results suggested that the 3 terminus
of ORF-E RNA in TG was different at different times after
BHV-1 infection. During acute infection and when reactiva-
tion was initiated with dexamethasone, the ORF-E RNA was
longer at its 3 terminus than it was during latency.
Additional studies were subsequently performed to deter-
mine whether the ORF-E RNA was polyadenylated and which
polyadenylation signal was used. To this end, MDBK cells were
infected with BHV-1, and total RNA was extracted. First-
FIG. 6. Localization of the 3 terminus of the ORF-E RNA.
(A) MDBK cells were infected with BHV-1, and total RNA was ex-
tracted at 6 h postinfection. Strand-specific cDNA synthesis was per-
formed with 1 g of total RNA with the indicated primers (1, 2, 3, 4,
or 5) that are shown in Fig. 4. PCR was performed with the indicated
primers. (B) Calves were infected with BHV-1 as described in Mate-
rials and Methods, and TG were extracted at the indicated times
postinfection. Latently infected calves (60 days postinfection) were
treated with 100 mg of dexamethasone as described previously to
induce reactivation from latency (15), and RNA was extracted 21 h
later (React.). The numbers above the line indicate which primer was
used for strand-specific cDNA synthesis. PCR was performed with
primers 478 and 695. The arrow denotes the expected size of the PCR
product.
FIG. 5. Mapping the 5 region of the ORF-E RNA. (A) MDBK
cells were infected with BHV-1, and total RNA or DNA was extracted
at 6 h postinfection. Strand-specific cDNA synthesis was performed
with 1 g of total RNA with either primer 487 or 348. PCR was
performed with the indicated primers. (B) Calves were infected with
BHV-1, and TG were extracted at either 6 days postinfection (calf 1)
or during latency at 60 days postinfection (calf 2). Strand-specific
cDNA synthesis was performed with 2 g of total RNA and primer
487. PCR amplification of cDNA products was performed with primers
487 and 348. The arrow denotes the expected band.
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strand synthesis was oligo(dT) primed, and PCR was per-
formed with primers 308 and 598. A PCR product was detected
at 4 and 9 h after infection (Fig. 7A, last two lanes). With the
same RNA, strand-specific RT-PCR was performed and re-
sults similar to those shown in Fig. 2 were obtained. The
polyadenylated transcript detected in the oligo(dT)-primed re-
action was ORF-E and not the LR gene because the 5 termi-
nus of the LR RNA is downstream of primer 308 during
productive infection (13) (Fig. 1B). The PCR product was not
likely bICP0 because the polyadenylation signal for bICP0 is
located at nucleotide 960 (see Fig. 1 and 4) (31).
Transient-transfection assays were used to further test
whether the ORF-E transcript could actually terminate at the
first polyadenylation signal at the GGGCTT motif near nucle-
otides 20 to 30 (Fig. 4). The PstI fragment (Fig. 1C) was cloned
into pUC19 and the mammalian vector pCDNA3.1. pUC19
does not have a known mammalian polyadenylation signal,
whereas pCDNA3.1 contains the simian virus 40 polyadenyla-
tion signals. We predicted that if a pUC19 plasmid containing
the ORF-E gene was transfected into mammalian cells, an
RT-PCR product would be amplified from oligo(dT)-primed
RT-PCR if polyadenylation occurred at the GGGCTT motif.
We also expected that the ORF-E transcript would be polyad-
enylated when cloned into a pcDNA3.1-based vector. These
two plasmids were transfected into neuro-2A cells, and total
RNA was extracted 48 h later. Random primers and oligo(dT)
were used in the first-strand synthesis reactions. Both vectors
expressed an ORF-E transcript that was detected by either
random priming or oligo(dT) (Fig. 6B). These products were
derived from cDNA because when reverse transcriptase was
omitted from the reaction, the PCR product was not detected.
In summary, the ORF-E transcript appears to utilize different
polyadenylation sites during latency versus productive infec-
tion.
Localization of the ORF-E protein in transfected cells. Stud-
ies were performed to test whether ORF-E was produced in
transfected cells and, if so, to examine its subcellular localiza-
tion. The putative protein-coding sequences of ORF-E (Fig. 4)
were cloned upstream of the GFP coding sequences in
phMGFP. The ORF-E/GFP plasmid and the blank GFP vector
were transfected into two nonneuronal (MDBK and rabbit
skin) and two neuronal (neuro-2A and SK-N) cell lines. The
ORF-E/GFP fusion protein was localized to the nucleus when
expressed in neuro-2A cells and SK-N cells (Fig. 8). The ex-
pression of the fusion protein was punctate and appeared to be
localized to distinct nuclear regions. GFP expression was not
detected in the projections (dendrites) of the neuron-like cells
when transfected with ORF-E/GFP. In contrast, neuro-2A and
SK-N-SH cells transfected with the blank GFP expression vec-
tor (phMGFP) contained GFP throughout the cell, including
the dendrites. When the ORF-E/GFP fusion was transfected
into RS cells, the expression pattern was still punctate, but the
fusion protein was detected in the nucleus and cytoplasm. A
similar expression pattern was observed when MDBK cells
were transfected with the ORF-E/GFP fusion vector (data not
shown). In summary, this study suggested that ORF-E was
localized to the nucleus of neuronal cells.
DISCUSSION
This report describes the identification of a transcript that
contains a 135-amino-acid open reading frame, ORF-E. The
ORF-E transcript is antisense to the LR gene and was consis-
tently expressed during latency. Although we were unable to
detect the ORF-E transcript by Northern analysis, the ORF-E
transcript was readily detected by RT-PCR with strand-specific
primers used to initiate cDNA synthesis. This is similar to the
herpes simplex virus type 1 AL gene and the UL43 gene, which
were not detected by Northern blotting but were detected by
RT-PCR (5, 22). When ORF-E was fused to GFP, this fusion
protein was expressed in the nucleus of transfected neuronal
cells.
The herpes simplex virus type 1 AL transcript (antisense to
LAT) contains an ORF that is expressed upstream and anti-
sense of herpes simplex virus type 1 LAT (22). The AL tran-
script overlaps 198 nucleotides of the LAT promoter and 158
nucleotides of the 5 end of the primary 8.3-kb LAT transcript.
The sequence of the AL ORF is highly conserved among
different herpes simplex virus type 1 isolates that have been
sequenced, suggesting that this protein is expressed. The find-
ing that sera from infected rabbits recognize peptides from the
AL ORF (22) supports the prediction that this protein is ex-
pressed. Although the AL gene and the ORF-E gene occupy
similar locations on their respective genomes, there is no ob-
FIG. 7. Is the ORF-E transcript polyadenylated in transfected
cells? (A) MDBK cells were infected with BHV-1, and total RNA was
prepared at the indicated times. RT-PCR was performed with strand-
specific or oligo(dT) primers to synthesize cDNA. PCR was performed
with the same primers (308 and 598) for all reactions. (B) The PstI
fragment shown in Fig. 1 was cloned into either pUC19 or pCDNA3.1.
Neuro-2A cells were transfected with the designated plasmid, and at
48 h posttransfection total RNA was prepared. cDNA was synthesized
with random primers or oligo(dT) primers. PCR was then performed
with the same primers for all reactions (478 and 598). Lanes 1, cells
transfected with pUC19-ORF-E. Lanes 2, cells transfected with
pCDNA3.1-ORF-E. RT-, reverse transcriptase was not added to the
reaction;, no-template control;, BHV-1 DNA. As another control,
-actin primers were used in the PCR on the same reactions.
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FIG. 8. Localization of ORF-E expression. The designated cells were transfected with 2 g of the ORF-E/GFP plasmid or the GFP blank
expression vector phMGFP. At 24 h after transfection, cells were viewed by confocal microscopy. The panels on the left are fluorescent images,
and those on the right are differential interference/phase contrast images (see Materials and Methods). The magnification was 160 for SK-N-SH
cells and 240 for neuro-2A and RS cells. The arrows denote GFP-positive cells. These images are representative of many cells that were
examined.
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vious amino acid sequence similarity between the putative
ORF-E protein and the AL protein (data not shown). Among
the BHV-1 isolates that have been sequenced, the ORF-E
amino acid sequences are highly conserved. In contrast, an
ORF-E gene was not detected at the same location on the
BHV-5 genome (9). Although the genomes of BHV-1 and
BHV-5 are very similar, BHV-5 causes severe central nervous
disorders in cattle, whereas BHV-1 primarily induces upper
respiratory tract disorders and conjunctivitis. The most dra-
matic difference in the genomes of BHV-1 and BHV-5 was the
LR gene locus, including the ORF-E coding sequences. Since
it was hypothesized that differences in the biological properties
of BHV-1 and BHV-5 are linked to differences in the LR gene
locus (9), it is logical to speculate that ORF-E may contribute
to these differences.
The 5 terminus of the ORF-E transcript was localized to
sequences that were adjacent to the 3 terminus of bICP0 (Fig.
4). The putative ATG for ORF-E is more than 200 bp down-
stream from this region. This result was unexpected because
the AT-rich motif that is present within the LR promoter (Fig.
1C) was downstream of the 5 terminus of the ORF-E tran-
script, suggesting that this was the ORF-E promoter. However,
our results suggested that ORF-E promoter sequences are
located within the bICP0 coding sequences. The finding that
more than one 3 end exists for the ORF-E transcript was also
not expected. We suggest that virus-encoded and induced func-
tions and neuron-specific factors regulate the selection of poly-
adenylation sites. It is also possible that a family of ORF-E
transcripts are synthesized, which would have complicated
mapping the 5 and 3 termini. This possibility is supported by
the fact that the LR gene encodes a family of transcripts, some
of which are alternatively spliced (10, 13). Since ORF-E and
the LR gene are both consistently expressed during latency, we
suggest that these genes regulate each other’s expression
and/or work in conjunction to promote latency. Studies to
address what role the ORF-E gene plays in the latency reac-
tivation cycle of BHV-1 are in progress.
We predict that ORF-E encodes a regulatory protein in
neurons because the ORF-E/GFP fusion protein was primarily
detected in the nucleus of transfected neuronal cells (Fig. 8).
The cells transfected with ORF-E/GFP continued to grow
(data not shown). In contrast, the LR gene induced cell cycle
arrest (25), and the bICP0 gene is cytotoxic (16). Although we
do not know the function of the ORF-E gene, it seems clear
that it has novel functions relative to the LR gene and bICP0.
The LR gene has antiapoptotic activity (7, 21). In contrast, our
studies indicate that the ORF-E gene does not protect cells
against an apoptotic insult in vitro (data not shown). Sequence
analysis of the putative protein encoded by ORF-E suggested
that it can be myristoylated, glycosylated, and phosphorylated.
Amino acid sequences near the N terminus of ORF-E can be
found in other proteins that have anti-inflammatory properties.
Infiltration of immune cells into TG plays an active role in
maintaining latency (19), suggesting that the ORF-E protein
may dampen the effects of infiltrating immune cells on infected
neurons. We recently expressed the ORF-E protein in a bac-
ulovirus system, and thus we should be able to generate anti-
bodies that will be useful for detecting ORF-E protein expres-
sion after infection.
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